• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用双重稳健估计量对比治疗特异性生存。

Contrasting treatment-specific survival using double-robust estimators.

机构信息

Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109-2029, USA.

出版信息

Stat Med. 2012 Dec 30;31(30):4255-68. doi: 10.1002/sim.5511. Epub 2012 Jul 16.

DOI:10.1002/sim.5511
PMID:22807175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4180679/
Abstract

In settings where a randomized trial is infeasible, observational data are frequently used to compare treatment-specific survival. The average causal effect (ACE) can be used to make inference regarding treatment policies on patient populations, and a valid ACE estimator must account for imbalances with respect to treatment-specific covariate distributions. One method through which the ACE on survival can be estimated involves appropriately averaging over Cox-regression-based fitted survival functions. A second available method balances the treatment-specific covariate distributions through inverse probability of treatment weighting and then contrasts weighted nonparametric survival function estimators. Because both methods have their advantages and disadvantages, we propose methods that essentially combine both estimators. The proposed methods are double robust, in the sense that they are consistent if at least one of the two working regression models (i.e., logistic model for treatment and Cox model for death hazard) is correct. The proposed methods involve estimating the ACE with respect to restricted mean survival time, defined as the area under the survival curve up to some prespecified time point. We derive and evaluate asymptotic results through simulation. We apply the proposed methods to estimate the ACE of donation-after-cardiac-death kidney transplantation with the use of data obtained from multiple centers in the Netherlands.

摘要

在无法进行随机试验的情况下,通常会使用观察性数据来比较特定治疗方法的生存情况。平均因果效应(ACE)可用于对患者群体的治疗政策进行推断,而有效的 ACE 估计量必须考虑到治疗特定协变量分布的不平衡。一种估计生存 ACE 的方法涉及通过适当平均基于 Cox 回归的拟合生存函数来实现。另一种可用的方法通过治疗的逆概率加权来平衡特定治疗的协变量分布,然后对比加权非参数生存函数估计量。由于这两种方法都有其优点和缺点,因此我们提出了实质上结合这两种估计量的方法。所提出的方法是双重稳健的,因为只要两个工作回归模型(即治疗的逻辑模型和死亡风险的 Cox 模型)之一是正确的,它们就是一致的。所提出的方法涉及使用受限平均生存时间(即在特定时间点之前生存曲线下的面积)来估计 ACE。我们通过模拟得出并评估了渐近结果。我们应用所提出的方法来估计荷兰多个中心获得的数据中,心死亡后肾移植的 ACE。

相似文献

1
Contrasting treatment-specific survival using double-robust estimators.使用双重稳健估计量对比治疗特异性生存。
Stat Med. 2012 Dec 30;31(30):4255-68. doi: 10.1002/sim.5511. Epub 2012 Jul 16.
2
Methods for comparing center-specific survival outcomes using direct standardization.使用直接标准化比较特定中心生存结局的方法。
Stat Med. 2014 May 30;33(12):2048-61. doi: 10.1002/sim.6089. Epub 2014 Jan 17.
3
Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.在不假设风险比例的情况下,提高对具有生存结局的随机试验分析的精度。
Lifetime Data Anal. 2019 Jul;25(3):439-468. doi: 10.1007/s10985-018-9428-5. Epub 2018 Feb 28.
4
Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.分层抽样观察性研究中特定治疗生存分布的双重稳健估计量。
Biometrics. 2013 Dec;69(4):830-9. doi: 10.1111/biom.12076. Epub 2013 Oct 11.
5
Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.使用伪观测值估计受限平均生存时间差异的双重稳健方法。
Pharm Stat. 2022 Nov;21(6):1185-1198. doi: 10.1002/pst.2223. Epub 2022 May 7.
6
Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.非比例风险和相依删失下累积治疗效果的双重逆加权估计
Biometrics. 2011 Mar;67(1):29-38. doi: 10.1111/j.1541-0420.2010.01449.x.
7
Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.在可能预期治疗效果存在非比例风险的临床试验设计中增强对数秩检验。
BMC Med Res Methodol. 2016 Feb 11;16:16. doi: 10.1186/s12874-016-0110-x.
8
Semiparametric methods to contrast gap time survival functions: Application to repeat kidney transplantation.对比间隔时间生存函数的半参数方法:在重复肾移植中的应用。
Biometrics. 2016 Jun;72(2):525-34. doi: 10.1111/biom.12427. Epub 2015 Oct 26.
9
Evaluating bias correction in weighted proportional hazards regression.评估加权比例风险回归中的偏差校正
Lifetime Data Anal. 2009 Mar;15(1):120-46. doi: 10.1007/s10985-008-9102-4. Epub 2008 Oct 29.
10
Doubly robust matching estimators for high dimensional confounding adjustment.用于高维混杂因素调整的双稳健匹配估计量。
Biometrics. 2018 Dec;74(4):1171-1179. doi: 10.1111/biom.12887. Epub 2018 May 11.

引用本文的文献

1
Prescribing methadone in prison predicts linkage to HIV care after release from prison: A randomized and patient preference trial.在监狱中开具美沙酮处方可预测出狱后与艾滋病护理的联系:一项随机且基于患者偏好的试验。
Int J Drug Policy. 2025 Mar;137:104733. doi: 10.1016/j.drugpo.2025.104733. Epub 2025 Feb 8.
2
Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma.用于估计生存结局平均治疗效果的匹配加回归调整:以莫苏奈妥珠单抗治疗复发/难治性滤泡性淋巴瘤为例
BMC Med Res Methodol. 2025 Feb 1;25(1):30. doi: 10.1186/s12874-025-02456-x.
3
Causal effect estimation in survival analysis with high dimensional confounders.高维混杂因素生存分析中的因果效应估计。
Biometrics. 2024 Oct 3;80(4). doi: 10.1093/biomtc/ujae110.
4
Inference for treatment-specific survival curves using machine learning.使用机器学习对特定治疗的生存曲线进行推断。
J Am Stat Assoc. 2024;119(546):1541-1553. doi: 10.1080/01621459.2023.2205060. Epub 2023 Jun 5.
5
Multiply robust estimator for the difference in survival functions using pseudo-observations.使用伪观测值的生存函数差异的多重稳健估计量。
BMC Med Res Methodol. 2023 Oct 23;23(1):247. doi: 10.1186/s12874-023-02065-6.
6
Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target population.用于将随机对照试验中生存结局的治疗效果推广到目标人群的双重稳健估计量。
J Causal Inference. 2022;10(1):415-440. doi: 10.1515/jci-2022-0004. Epub 2022 Dec 9.
7
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.高危前列腺癌伴不良临床病理特征患者的多模式治疗比较及结果。
JAMA Netw Open. 2021 Jul 1;4(7):e2115312. doi: 10.1001/jamanetworkopen.2021.15312.
8
Estimating heterogeneous survival treatment effect in observational data using machine learning.利用机器学习估计观察性数据中异质生存治疗效果。
Stat Med. 2021 Sep 20;40(21):4691-4713. doi: 10.1002/sim.9090. Epub 2021 Jun 10.
9
Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets.将橘子变成苹果:比较在调整不同协变量集后不可折叠的效应估计量及其标准误差。
Biom J. 2021 Mar;63(3):528-557. doi: 10.1002/bimj.201900297. Epub 2020 Dec 14.
10
Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.存在与时间相关的协变量的删失依赖性下风险的双重稳健估计:普伐他汀治疗冠心病一级预防试验的应用。
BMC Med Res Methodol. 2020 Jul 31;20(1):204. doi: 10.1186/s12874-020-01087-8.

本文引用的文献

1
Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.非比例风险和相依删失下累积治疗效果的双重逆加权估计
Biometrics. 2011 Mar;67(1):29-38. doi: 10.1111/j.1541-0420.2010.01449.x.
2
Kidneys from donors after cardiac death provide survival benefit.心脏死亡供体的肾脏可带来生存获益。
J Am Soc Nephrol. 2010 Jun;21(6):1015-21. doi: 10.1681/ASN.2009121203. Epub 2010 May 20.
3
Pseudo-observations in survival analysis.生存分析中的伪观测。
Stat Methods Med Res. 2010 Feb;19(1):71-99. doi: 10.1177/0962280209105020. Epub 2009 Aug 4.
4
Survival benefit-based deceased-donor liver allocation.基于生存获益的脑死亡供体肝脏分配
Am J Transplant. 2009 Apr;9(4 Pt 2):970-81. doi: 10.1111/j.1600-6143.2009.02571.x.
5
Comment: Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data.评论:揭开双重稳健性的神秘面纱:从不完整数据估计总体均值的替代策略比较。
Stat Sci. 2007;22(4):569-573. doi: 10.1214/07-STS227.
6
Doubly robust estimation in missing data and causal inference models.缺失数据与因果推断模型中的双重稳健估计
Biometrics. 2005 Dec;61(4):962-73. doi: 10.1111/j.1541-0420.2005.00377.x.
7
Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.针对生存数据,采用治疗权重逆概率的调整后Kaplan-Meier估计器和对数秩检验。
Stat Med. 2005 Oct 30;24(20):3089-110. doi: 10.1002/sim.2174.
8
Regression analysis of restricted mean survival time based on pseudo-observations.基于伪观测值的受限平均生存时间回归分析。
Lifetime Data Anal. 2004 Dec;10(4):335-50. doi: 10.1007/s10985-004-4771-0.
9
Adjusted survival curves with inverse probability weights.采用逆概率加权法调整后的生存曲线。
Comput Methods Programs Biomed. 2004 Jul;75(1):45-9. doi: 10.1016/j.cmpb.2003.10.004.
10
Causal inference on the difference of the restricted mean lifetime between two groups.两组之间受限平均寿命差异的因果推断。
Biometrics. 2001 Dec;57(4):1030-8. doi: 10.1111/j.0006-341x.2001.01030.x.